Search

everythingexperts & clinicslearnresearchcommunity

for

Search:↓

Younger mice's hair-follicle stem cells are better at turning into heart cells than older mice's.

Exosomes show promise for improving wound healing, reducing aging signs, preventing hair loss, and lightening skin but require more research and better production methods.

Injecting specific cells into the skin can help improve skin structure and reduce blisters in a genetic skin disorder.

The new microwell device helps grow more hair stem cells that can regenerate hair.

New methods to test hair growth treatments have been developed.

Targeting non-Smad pathways in TGF-β signaling may improve keloid treatment.

Alopecia areata causes hair loss due to immune issues, and while new treatments show promise, no universally effective solution exists yet.

Type XVII collagen helps control skin cell growth and may have anti-aging effects.

Type XVII collagen may help prevent skin aging.

Ritlecitinib helps regrow hair in people with alopecia totalis and universalis and is safe to use.

TEC kinases may help cause inflammation in vitiligo and could be targeted for treatment.

Ritlecitinib may help treat alopecia areata by protecting hair follicles.

Ritlecitinib reduces alopecia areata symptoms by blocking JAK3/TEC signaling and T-cell activity.

ITK inhibitors may effectively treat alopecia areata.

Ritlecitinib is safe and well-tolerated for treating alopecia areata in patients aged 12 and older.

Deleting the p63 gene in certain cells causes problems in thymus development and severe hair loss in mice.

The FDA approved a new Pfizer drug for hair loss in teens.

Ritlecitinib may be more effective for severe alopecia areata than conventional treatments.

Chemotherapy and radiotherapy can cause skin side effects like rashes, hair loss, and nail changes, which are usually managed with conservative treatments.

Ritlecitinib is being tested for safety and effectiveness in young children with severe alopecia areata.

Ritlecitinib is cost-effective for severe alopecia areata in Japan.

Ritlecitinib shows promise in improving hair regrowth in adolescents with alopecia areata.

Ritlecitinib effectively regrows scalp, eyebrow, and eyelash hair in Asians with alopecia areata and is safe.

Ritlecitinib is generally safe for long-term use, with mostly mild side effects.

Ritlecitinib effectively reduces hair loss in JAK inhibitor-naïve alopecia areata patients.

Ritlecitinib effectively treats severe Alopecia Areata by reducing harmful immune activity in the skin.

Ritlecitinib may cause serious side effects like blood clots in alopecia areata patients.

Ritlecitinib effectively treats alopecia areata in patients 12 and older with fewer side effects.

Ritlecitinib effectively improves hair growth in alopecia areata patients, regardless of hair loss pattern.

Ritlecitinib effectively treats alopecia areata and is well-tolerated.